TGFB1 and liver disorder: Notably, during liver disease, chronic inflammation, profound tissue remodeling, and genetic alterations result in the production of both pro-inflammatory (e.g., IL-6, TNF-α) and/or anti-inflammatory or immuno-suppressive (e.g., TGF-β, IL-10) cytokines (9).